Posts tagged Ocular Therapeutix Inc


Ocular Therapeutix Inc (OCUL) Gets A Bullish Vote Following 2Q:17 Update

Ocular Therapeutix Inc (NASDAQ:OCUL) shares are on a roughly 4% dip today after the biotech …

Read more

Two Biotech Stocks to Watch: Spark Therapeutics Inc (ONCE) and Ocular Therapeutix Inc (OCUL)

Spark Therapeutics Has a Viable Hep A Program on Its Hands Spark Therapeutics Inc (NASDAQ:ONCE) …

Read more

H.C. Wainwright Takes Ocular Therapeutix Inc’s (OCUL) Restructuring Plan in Bullish Stride as Shares Dip 5%

Ocular Therapeutix Inc (NASDAQ:OCUL) shares are sliding almost 5% today on the heels of the …

Read more

Wednesday’s Biotech Movers: Ibio Inc (IBIO) Rallies, Ocular Therapeutix Inc (OCUL) Tumbles, Alder Biopharmaceuticals Inc (ALDR) Dives

Ibio Inc (NYSEMKT:IBIO) shares are rising fast in Wednesday’s trading session. Currently shares in the …

Read more

BTIG Shares Two Cents on Ocular Therapeutix Inc (OCUL) Following CRL for DEXTENZA

BTIG analyst Dane Leone is out today with a research note on shares of Ocular Therapeutix Inc …

Read more

Why Cantor Just Slashed the Price Target for Ocular Therapeutix Inc (OCUL)

Ocular Therapeutix Inc (NASDAQ:OCUL) shares slumped nearly 20% after the drug maker announced that it received …

Read more

A Glimpse Into Two Climbing Biotechs: Arena Pharmaceuticals, Inc. (ARNA) and Ocular Therapeutix Inc (OCUL)

Arena Pharmaceuticals, Inc. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares jumped nearly 50% in Tuesday’s trading session, after …

Read more

Ocular Therapeutix Inc (OCUL) Soars 20% After Making Move to Resolve Dextenza Manufacturing Issues; Cantor Weighs In

Ocular Therapeutix Inc (NASDAQ:OCUL) shares may have been falling almost 9% at the close on …

Read more

Why These Biotech Stocks Tumbled Today: Ocular Therapeutix Inc (OCUL) and bluebird bio Inc (BLUE)

Ocular Therapeutix Inc Ocular Therapeutix Inc (NASDAQ:OCUL) investors seem to be concerned with the company’s future …

Read more

Valeant Pharmaceuticals Intl Inc (VRX) Still on a Rocky Debt Road, Ocular Therapeutix Inc (OCUL) Struck with a Downgrade

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is a biotech giant that continues to struggle, and ahead …

Read more